Malaria: a research agenda for the eradication era

W Kilama, F Ntoumi - The Lancet, 2009 - thelancet.com
The world's largest meeting on malaria, the 5th Multilateral Initiative on Malaria (MIM) Pan-
African Malaria Conference, convenes in Nairobi, Kenya, on Nov 1–6. 1 Since the last MIM …

Resistance to chloroquine unhinges vivax malaria therapeutics

JK Baird - Antimicrobial agents and chemotherapy, 2011 - Am Soc Microbiol
After 6 decades during which it was almost completely neglected, malaria workers have
begun to acknowledge that vivax malaria poses a serious threat to human health. Nearly 3 …

Update on prevention of malaria for travelers

HO Lobel, PE Kozarsky - Jama, 1997 - jamanetwork.com
Individuals from industrialized nations frequently travel to countries with malaria, so health
care providers need to be familiar with current recommendations for prevention of malaria …

Malaria: an update on current chemotherapy

BJ Visser, M van Vugt, MP Grobusch - Expert opinion on …, 2014 - Taylor & Francis
Introduction: Chemotherapy of malaria has become a rapidly changing field. Less than two
decades ago, treatment regimens were increasingly bound to fail due to emerging drug …

[PDF][PDF] Four malaria success stories: how malaria burden was successfully reduced in Brazil, Eritrea, India, and Vietnam

LM Barat - American Journal of Tropical Medicine and Hygiene, 2006 - Citeseer
While many countries struggle to control malaria, four countries, Brazil, Eritrea, India, and
Vietnam, have successfully reduced malaria burden. To determine what led these countries …

Adjunctive therapy for severe malaria: a review and critical appraisal

R Varo, VM Crowley, A Sitoe, L Madrid, L Serghides… - Malaria journal, 2018 - Springer
Background Despite recent efforts and successes in reducing the malaria burden globally,
this infection still accounts for an estimated 212 million clinical cases, 2 million severe …

Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis

RN Price, L Von Seidlein, N Valecha… - The Lancet infectious …, 2014 - thelancet.com
Background Chloroquine is the first-line treatment for Plasmodium vivax malaria in most
endemic countries, but resistance is increasing. Monitoring of antimalarial efficacy is …

Guidelines for malaria vector control

L Choi, J Pryce, M Richardson, V Lutje… - World Health …, 2019 - archive.lstmed.ac.uk
Malaria remains an important cause of illness and death in children and adults throughout
the world, with 87 countries reporting one or more cases of malaria in 2017. Malaria control …

A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru

T Grande, A Bernasconi, A Erhart, D Gamboa… - PLoS …, 2007 - journals.plos.org
Background Multi-drug resistant falciparum malaria is an important health problem in the
Peruvian Amazon region. We carried out a randomised open label clinical trial comparing …

Modern chemotherapeutic options for malaria

P Winstanley - The Lancet infectious diseases, 2001 - thelancet.com
Unlike HIV disease or tuberculosis, both of which are also major threats to public health
throughout the tropics, uncomplicated malaria of whatever species can be cheaply and …